Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2026-03-01
סדרה:	JEADV Clinical Practice
נושאים:	atopic dermatitis biologics JAK inhibitors real‐world evidence
גישה מקוונת:	https://doi.org/10.1002/jvc2.70153
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!